Terson syndrome
Terson Syndrome[edit | edit source]
Terson syndrome is a medical condition characterized by the occurrence of vitreous hemorrhage in association with subarachnoid hemorrhage or intracranial hemorrhage. It is named after the French ophthalmologist Albert Terson, who first described the condition in 1900.
Pathophysiology[edit | edit source]
Terson syndrome occurs when there is a sudden increase in intracranial pressure due to bleeding in the brain, such as a subarachnoid hemorrhage. This increased pressure can lead to rupture of small blood vessels in the eye, resulting in hemorrhage into the vitreous body, the clear gel that fills the space between the lens and the retina.
Clinical Presentation[edit | edit source]
Patients with Terson syndrome may present with sudden loss of vision or visual disturbances. The severity of visual impairment depends on the extent of the hemorrhage. In some cases, the hemorrhage may resolve spontaneously, but in others, surgical intervention may be required to clear the blood from the vitreous cavity.
Diagnosis[edit | edit source]
The diagnosis of Terson syndrome is typically made based on clinical examination and imaging studies. An ophthalmologist may use ophthalmoscopy to visualize the vitreous hemorrhage. CT scan or MRI of the brain may be performed to identify the underlying cause of the increased intracranial pressure.
Treatment[edit | edit source]
Treatment of Terson syndrome focuses on managing the underlying cause of the intracranial hemorrhage and addressing the vitreous hemorrhage. In cases where the vitreous hemorrhage does not resolve on its own, a surgical procedure called vitrectomy may be performed to remove the blood and restore vision.
Prognosis[edit | edit source]
The prognosis for patients with Terson syndrome varies depending on the severity of the intracranial hemorrhage and the extent of the vitreous hemorrhage. Early diagnosis and treatment of the underlying cause are crucial for improving outcomes.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
